MOBEUS INCOME & GROWTH 2 VCT PLC
("the Company")
LEI: 213800LY62XLI1B4VX35
INTERIM MANAGEMENT STATEMENT
For the quarter ended 30 June 2023
Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.
NET ASSET VALUE AND TOTAL RETURN PER SHARE
|
| At 30 June 2023 (unaudited) | At 31 March 2023 (audited) |
| Net assets attributable to shareholders | £71,597,619 | £70,426,557 |
| Shares in issue | 98,437,045 | 98,437,045 |
| Net asset value (NAV) per share | 72.73p | 71.54p |
| Cumulative dividends paid | 147.00p | 147.00p |
| Cumulative Total return (net asset value basis) per share since inception | 219.73p | 218.54p |
Net asset value (NAV) per share has increased by 1.19 pence, or 1.7% over the period. This increase is primarily due to a rise in unrealised valuations over the first three months of the financial year. No dividends have been paid in the period.
INVESTMENT ACTIVITY DURING THE PERIOD
New Investments
On 3 May 2023, a new equity investment of £0.39 million was made into Dayrize B.V., a provider of a rapid sustainability impact assessment tool.
Share Buybacks
No shares were bought back in the quarter.
INVESTMENT ACTIVITY AFTER THE PERIOD END
New investments after the period end
On 26 July 2023, a new equity investment of £0.32 million was made into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.
On 3 August 2023, a new equity investment of £0.32 million was made into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.
Follow-on investments after the period end
On 4 July 2023, a follow on equity investment of £0.30 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.
On 11 August 2023, a follow on loan investment of £0.11 million was made into Orri, an intensive day care provider for adults with eating disorders.
Share Buybacks after the period end
On 18 July 2023, the Company purchased 336,876 of its own ordinary shares at a price of 67.96 pence per share.
All shares bought back by the Company were subsequently cancelled.
Please note that all of the above information is unaudited.
Other than as described above, there were no material events during the period and to the date of this announcement.
For further information, please contact:
Gresham House Asset Management Limited,
Company Secretary
020 7382 0999
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.